Alpha Wealth Funds’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Alpha Wealth Funds's ARKG Position: Q1 2025 in Review
Alpha Wealth Funds sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 20,000 shares — an estimated $471K sold.
Alpha Wealth Funds first reported a position in ARKG in Q4 2024 and held it in 1 quarter. The position peaked at $471K in Q4 2024. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.
- Alpha Wealth Funds reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
- Alpha Wealth Funds sold 20,000 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $471K.
- Alpha Wealth Funds first reported a position in ARK Genomic Revolution ETF in Q4 2024 and held it in 1 quarter.
- Alpha Wealth Funds's ARK Genomic Revolution ETF position peaked at $471K in Q4 2024.
- 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.
Based on Alpha Wealth Funds's 13F filing for Q1 2025, filed 10 Apr 2025.